Logo image
Management of Anemia in Children Undergoing Dialysis
Book chapter

Management of Anemia in Children Undergoing Dialysis

Carlos E. Araya and Joshua J. Zaritsky
Handbook of Dialysis Therapy, pp 778-788
01 Jan 2022

Abstract

erythropoietic stimulating agents iron metabolism pediatric nephrology Anemia
Anemia is common and associated with adverse outcomes in children with chronic kidney disease. The management of anemia was dramatically changed due to the development of erythropoiesis-stimulating agents (ESAs) and new understandings of iron metabolism. As the adverse effects of anemia have become more apparent and concerning, there has been a push to optimize ESA and iron therapy. This chapter will review the basic management of anemia in children undergoing dialysis and should provide a practical approach to the day-to-day management of anemia in children who require renal replacement therapy.

Metrics

1 Record Views

Details

Logo image